Utility of Integrated Computed Tomography-Positron Emission Tomography for Selection of Operable Malignant Pleural Mesothelioma

被引:25
|
作者
Wilcox, Brad E. [1 ]
Subramaniam, Rathan M. [2 ]
Peller, Patrick J. [2 ]
Aughenbaugh, Gregory L. [2 ]
Nichols, Francis C., III [3 ]
Aubry, Marie Christine [4 ]
Jett, James R. [1 ]
机构
[1] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Surg, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA
关键词
Extrapleural pneumonectomy; Locoregional disease; Parietal pleurectomy; Tumor-node-metastasis staging; EXTRAPLEURAL PNEUMONECTOMY; PREOPERATIVE EVALUATION; CHEMOTHERAPY; RESECTION; SURVIVAL; THERAPY; TRENDS; PET; CT;
D O I
10.3816/CLC.2009.n.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Malignant pleural mesothelioma (MPM) is a primary malignancy characterized by local invasion of the pleura and metastasis. Despite advances in computed tomography (CT) and magnetic resonance imaging (MRI), accurately staging patients remains challenging. Recent studies have examined the use of integrated CT-positron emission tomography (PET) for staging patients. Materials and Methods: Mayo Clinic databases were queried to identify cases with a histologic diagnosis of MPM from 2000 to 2006. Inclusion criteria were a diagnosis of MPM, an available CT scan, and an initial staging integrated CT-PET scan. A total of 35 patients were identified who met the inclusion criteria. Computed tomography and integrated CT-PET scans were reviewed by experienced radiologists. Laboratory parameters were reviewed. The Mayo Clinic tumor registry and Social Security database were queried for survival data in patients in which no follow-up was available. Results: Findings on integrated CT-PET excluded 14 of 35 patients from surgical intervention. Extrapleural pneumonectomies (EPPs) were performed in 8 patients, and partial pleurectomies were performed in 2 patients. Upstaging from integrated CT-PET occurred in 70% of the patients when surgical pathology was available, 2 cases to an inoperable stage. Although not statistically significant, median survival was 20 months for patients undergoing an EPP and 12 months for patients excluded from surgical intervention by integrated CT-PET. Conclusion: Malignant pleural mesothelioma is a difficult disease to accurately stage. The most common reason for upstaging in our series was an increase in T (tumor; tumor-node-metastasis staging system) disease. Our data suggest that integrated CT-PET is excellent for detecting nodal and distant metastases. However, the ability of this imaging modality to correctly stage locoregional disease is not superior to the combination of CT and MRI as reported in the literature.
引用
收藏
页码:244 / 248
页数:5
相关论文
共 50 条
  • [1] Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications
    Erasmus, JJ
    Truong, MT
    Smythe, R
    Munden, RF
    Marom, EM
    Rice, DC
    Vaporciyan, AA
    Walsh, GL
    Sabloff, BS
    Broemeling, LD
    Stevens, CW
    Pisters, KM
    Podoloff, DA
    Macapinlac, HA
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (06): : 1364 - 1370
  • [2] Clinical utility of 18-fluorodeoxyglucose positron emission tomography/computed tomography in malignant pleural mesothelioma
    Terada, Takayuki
    Tabata, Chiharu
    Tabata, Rie
    Okuwa, Hisaya
    Kanemura, Shingo
    Shibata, Esuke
    Nakano, Takashi
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (02) : 197 - 200
  • [3] Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?
    Pinelli, Valentina
    Roca, Elisa
    Lucchini, Silvia
    Laroumagne, Sophie
    Loundou, Anderson
    Dutau, Herve
    Maldonado, Fabien
    Astoul, Philippe
    [J]. RESPIRATION, 2015, 89 (06) : 558 - 564
  • [4] Use of Computed Tomography and Positron Emission Tomography/Computed Tomography for Staging of Local Extent in Patients With Malignant Pleural Mesothelioma
    Frauenfelder, Thomas
    Kestenholz, Peter
    Hunziker, Roger
    Thi Dan Linh Nguyen
    Fries, Martina
    Veit-Haibach, Patrick
    Husmann, Lars
    Stahel, Rolf
    Weder, Walter
    Opitz, Isabelle
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2015, 39 (02) : 160 - 165
  • [5] CLINICAL SIGNIFICANCE OF 18-FLUORODEXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN MALIGNANT PLEURAL MESOTHELIOMA
    Terada, T.
    Tabata, C.
    Tabata, R.
    Okuwa, H.
    Kanemura, S.
    Shibata, E.
    Fukuoka, K.
    Nakano, T.
    [J]. RESPIROLOGY, 2012, 17 : 141 - 141
  • [6] Positron emission tomography predicts survival in malignant pleural mesothelioma
    Flores, Raja M.
    Akhurst, Timothy
    Gonen, Mithat
    Zakowski, Maureen
    Dycoco, Joseph
    Larson, Steven M.
    Rusch, Valerie W.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (04): : 763 - 768
  • [7] Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma - Initial results
    Plathow, Christian
    Staab, Adrian
    Schmaehl, Astrid
    Aschoff, Philip
    Zuna, Ivan
    Pfannenberg, Christina
    Peter, Schlemmer Heinz
    Eschmann, Susanne
    Klopp, Michael
    [J]. INVESTIGATIVE RADIOLOGY, 2008, 43 (10) : 737 - 744
  • [8] 18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma
    Subramaniam, R. M.
    Wilcox, B.
    Aubry, M. C.
    Jett, J.
    Peller, P. J.
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2009, 53 (02) : 160 - 169
  • [9] Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography
    Bénard, F
    Sterman, D
    Smith, RJ
    Kaiser, LR
    Albelda, SM
    Alavi, A
    [J]. CHEST, 1998, 114 (03) : 713 - 722
  • [10] Integrated Positron Emission Tomography-Computed Tomography Does Not Accurately Stage Intrathoracic Disease of Patients Undergoing Trimodality Therapy for Malignant Pleural Mesothelioma
    Pilling, J.
    Dartnell, J. -A.
    Lang-Lazdunski, L.
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2010, 58 (04): : 215 - 219